Letters

Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing

Disclosures: Dr Kohli-Pamnani reports consulting and speaking for Pfizer, outside of the submitted work. Dr Kwittken reports serving as a consultant on an advisory board meeting for Eyevance Pharmaceuticals LLC, outside of the submitted work. The remaining authors have no conflicts of interest to report.

Funding: The authors have no funding sources to report.